Answers are grounded in this paper and cite their sources.
The production of anti-idiotypic antibodies from Epstein-Barr virus transformed peripheral blood lymphocytes was analysed in 12 patients with multiple myeloma and monoclonal gammopathy of undetermined significance. A low anti-idiotype production was found in patients with advanced disease (multiple myeloma stage III), whereas the production was high in patients with multiple myeloma stage I and monoclonal gammopathy of undetermined significance (MGUS) (P less than 0.01). The study supports the existence of an immunological network response in patients with monoclonal gammopathies.
No takes yet. Share an insight, caveat, or question.
Bergenbrant et al. (1991) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: